Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease

Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease.

Cimzia (certolizumab pegol) is a tumor necrosis factor blocker... similar to Humira (adalimumab) and Remicade (infliximab).

Cimzia is "PEGylated" to extend its half-life. It can be given every 4 weeks...instead of every 2 weeks like Humira.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote